Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy.
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D001706:Biopsy; D003622:Dapsone / Q000627:therapeutic use; D004357:Drug Synergism; D004893:Erythema Nodosum / Q000188:drug therapy; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010619:Phenazines / Q000627:therapeutic use*; D012867:Skin / Q000382:microbiology
D000995:Antitubercular Agents; D010619:Phenazines; D003622:Dapsone; D007538:Isoniazid